| abstract |
The present invention generally relates to novel bispecific antigen binding molecules for T cell activation and redirection to specific target cells. The invention also relates to polynucleotides encoding such bispecific antigen binding molecules, as well as vectors and host cells comprising such polynucleotides. In addition, the present invention relates to methods of making the bispecific antigen binding molecules of the invention and to the use of these bispecific antigen binding molecules in the treatment of diseases. |